THPP-1 |
Inhibitor of PDE10A
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PDE10A |
|
|
50-200 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
PDE selectivity: closest hit is PDE6A (44 fold)
In Cell Selectivity Assessment
Selectivity Assessment Description:
Closest off-targets (Panlabs): Adenosine transporter (guinea pig): IC50 = 1.61 µM @ 10 µM
Potency Cellular
In Vitro
PDE10A
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmcl.2012.07.072
In Vivo Validations
Rat, Dog, Monkey
Dose: 1-10 mg/Kg
Route of delivery:
Oral
Plasma half life:
1.2 (R), 7.2 (D), 7.7 (M) h
Systemic clearance:
6.0 (R), 3.8 (D), 7.7(M) mL/min/kg
Bioavailability:
47% (R), 79% (D), 31% (M)
Organ of interest (O):
Brain
Target engagement assay:
Rat 6.0 1.4 47
Dog 3.8 7.2 79
Monkey 7.7 1.4 31
DOI Reference: 10.1016/j.bmcl.2012.07.072
Negative Control Compounds
THPP-1-NC
Chemical Information
| Molecular Formula | C23H21ClN6O3 |
| SMILEs | COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2 |
| InChI | InChI=1S/C23H21ClN6O3/c1-32-10-11-33-22-16-13-29(23(31)20-18-4-2-3-8-30(18)14-26-20)9-7-17(16)27-21(28-22)15-5-6-19(24)25-12-15/h2-6,8,12,14H,7,9-11,13H2,1H3 |
| Molecular weight | 464.14 Da |
| AlogP | 3.0634000000000015 |
| HBond acceptors | 9 |
| HBond donors | -- |
| Atoms | 54 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.
